Meropenem 1g powder for solution for injection vials
NHS hospitals in England used £57,828,778 of indicative cost of Meropenem 1g powder for solution for injection vials in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 1.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Meropenem 1g powder for solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Meropenem 1g powder for solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £2,589,785 |
| University Hpls Of Leicester Nhs Trust | £2,434,270 |
| Barts Health Nhs Trust | £1,600,915 |
| Manchester University Nhs Ft | £1,597,729 |
| Salford Royal Nhs Foundation Trust | £1,380,213 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,351,431 |
| Imperial College Healthcare Nhs Trust | £1,314,003 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,147,648 |
| Nottingham University Hospitals Trust | £1,132,228 |
| Royal Free London Nhs Foundation Trust | £1,094,495 |
The primary-care picture
Meropenem is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Meropenem medicine page.